BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2019
View Archived Issues
'Perpetrators and targets' of CTLA-4 signaling
Read More
Healing bones during cancer remission
Read More
Final phase I data from ZUMA-3 for Kite's KTE-X19 in adult ALL
Read More
Allena Pharmaceuticals presents interim results from Study 206 of reloxaliase
Read More
FDA clears IND for ALLO-715
Read More
First patient dosed in B-SIMPLE phase III program of SB-206
Read More
iPPS shows promising safety and efficacy in phase IIa study in chronic RRV-induced arthralgia
Read More
First-in-human results presented for ABBV-621
Read More
Phase I study confirms Apexian Pharmaceuticals' APX-3330 mediates APE-1 activity
Read More
CDX-3379 plus cetuximab shows clinical activity in patients with HNSCC
Read More
Merck & Co. describes new PRMT5 inhibitors
Read More
Arcutis begins phase IIa trial of ARQ-151 in atopic dermatitis
Read More
Bayer and The Broad Institute synthesize Mcl-1 inhibitors
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent anti-HBV compounds
Read More
New slective estrogen receptor degraders identified at Anlin Pharmaceuticals
Read More
Teligene discloses Bruton tyrosine kinase and/or HER2 inhibitors
Read More
Safety results from CITN-12 study on pembrolizumab in patients with HIV and cancer
Read More
Cellenkos initiates phase I trial of CK-0801 for bone marrow failure syndromes
Read More
Oncolytic virus works in pediatric brain tumors
Read More
FDA approves Emgality for episodic cluster headache
Read More
FDA accepts Prevail's IND for phase I/II study of PR-001 for Parkinson's disease with GBA1 mutation
Read More
AZP-3404 restores glucose homeostasis in leptin-deficient obese mice
Read More
Anxiolytic effect for JNJ-61393215 seen in humans
Read More
Aslan reports final results from single-ascending-dose study of ASLAN-004
Read More
Hemogenyx reports in vivo data on CDX bispecific antibody for AML
Read More
Phase II trial of risuteganib for dry AMD meets primary endpoint
Read More
IND cleared for phase II trial of zilucoplan in immune-mediated necrotizing myopathy
Read More
